World leaders in the field of genome based therapeutics in children will gather April 4-5 at Children’s Mercy Hospital, the UMKC School of Medicine’s primary teaching hospital for pediatric medicine, for the fourth annual Pediatric Pharmacogenomics and Personalized Medicine Conference.
Conference speakers are scheduled to include:
- Ron Krauss, Children’s Hospitals of Oakland Research Institute, “Metabolomics of Statin Response”
- Ron van Schaik, Erasmus MC, Rotterdam, The Netherlands, “Opiate Pharmacogenetics and Pain Response”
- Sara L Van Driest, Vanderbilt University School of Medicine, “Pediatric BioVU Program”
- James C McElnay, Queen’s University, Belfast, “Dried Blood Spot and Other Micro-Sampling Techniques to Characterize Phenotype in Children”
- John J Lima, Nemours Hospitals and Clinics, “Genetic Variation and Side Effects of Drugs in Children”
- Amanda Parker & Jennifer Lowry, Children’s Mercy Hospitals and Clinics, “Adverse Drug Reactions in Children”
- Sarah E Soden, Children’s Mercy Hospitals and Clinics, “Stat-Seq and the Project to Test Neonates”
- Mildred K Cho, Stanford Center for Biomedical Ethics, “Translating Genomics into the Clinic”
- Rosamond Rhodes, Mount Sinai School of Medicine, “Should There Be Any Restrictions on Genomic Testing of Newborns”
- Kelly Ormond, Stanford University, “Challenges in the Clinical Application of Whole-Genome Sequencing.”
To register online, go to www.regonline.com/pm2013.
